Suzuki S, Shapiro R, Mulrow P J, Tan S Y
Prostaglandins Med. 1980 May;4(5):377-82. doi: 10.1016/0161-4630(80)90011-7.
To ascertain whether renal prostaglandin E2 production is impaired in chronic renal disease we measured urinary prostaglandin E2 in 25 female renal patiens, and in 38 female noirmal volunteers. Prostaglandin E2 averaged 337 +/- 63 ng/24 hr in 25 female renal patients, which was significantly higher (P < 0.01) than values in normal female subjects (166 +/- 17 ng/24 hr). None of the renal patients excreted less than 50 ng/24 hr, whereas normals when treated with indomethacin averaged 30 +/- 10 ng/24 hr (n=8). There were no significant correlations between prostaglandin E2 and creatinine clearance, or urine volume. No difference in prostaglandin E2 was encountered between hypertensive and normotensive renal patients. Our results indicate that renal prostaglandin E2 production is increased rather than decreased in renal disease. The failure to demonstrate decreased urinary prostaglandin E2 excretion in renal hypertension sharply contrasts with the situation in essential hypertension.
为了确定慢性肾病患者肾脏前列腺素E2的生成是否受损,我们检测了25名女性肾病患者及38名正常女性志愿者的尿前列腺素E2。25名女性肾病患者尿前列腺素E2平均为337±63 ng/24小时,显著高于正常女性受试者(166±17 ng/24小时)(P<0.01)。没有一名肾病患者排泄量低于50 ng/24小时,而正常女性服用消炎痛后平均为30±10 ng/24小时(n = 8)。前列腺素E2与肌酐清除率或尿量之间无显著相关性。高血压肾病患者与血压正常的肾病患者之间前列腺素E2无差异。我们的结果表明,肾病时肾脏前列腺素E2的生成增加而非减少。肾性高血压患者尿前列腺素E2排泄未减少,这与原发性高血压的情况形成鲜明对比。